Compile Data Set for Download or QSAR
Report error Found 68 Enz. Inhib. hit(s) with all data for entry = 2119
TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354676(US9809582, Example 20 | Single diastereoisomers [(...)
Affinity DataIC50: 1nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354681(US9809582, Example 26 | US9809582, Example 27)
Affinity DataIC50: 1nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354666(US9809582, Example 9 | US9809582, Example 29 | US9...)
Affinity DataIC50: 1nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354671(US9809582, Example 15)
Affinity DataIC50: 1nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354685(US9809582, Example 30 | US9809582, Example 31)
Affinity DataIC50: 1nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354666(US9809582, Example 9 | US9809582, Example 29 | US9...)
Affinity DataIC50: 1nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354665(US9809582, Example 8 | US9809582, Example 25 | US9...)
Affinity DataIC50: 1nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354665(US9809582, Example 8 | US9809582, Example 25 | US9...)
Affinity DataIC50: 1nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354687(US9809582, Example 32 | US9809582, Example 34 | US...)
Affinity DataIC50: 1nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354664(US9809582, Example 7)
Affinity DataIC50: 1nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354663(US9809582, Example 5)
Affinity DataIC50: 1nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354673(US9809582, Example 17)
Affinity DataIC50: 1nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354674(US9809582, Example 18 | Single diastereoisomers of...)
Affinity DataIC50: 1nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354688(US9809582, Example 33 | US9809582, Example 36 | US...)
Affinity DataIC50: 1nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354678(US9809582, Example 22)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354678(US9809582, Example 22)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354677(US9809582, Example 21)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354665(US9809582, Example 8 | US9809582, Example 25 | US9...)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354677(US9809582, Example 21)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354676(US9809582, Example 20 | Single diastereoisomers [(...)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354681(US9809582, Example 26 | US9809582, Example 27)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354685(US9809582, Example 30 | US9809582, Example 31)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354681(US9809582, Example 26 | US9809582, Example 27)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354681(US9809582, Example 26 | US9809582, Example 27)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354666(US9809582, Example 9 | US9809582, Example 29 | US9...)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354688(US9809582, Example 33 | US9809582, Example 36 | US...)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354685(US9809582, Example 30 | US9809582, Example 31)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354688(US9809582, Example 33 | US9809582, Example 36 | US...)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354688(US9809582, Example 33 | US9809582, Example 36 | US...)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354687(US9809582, Example 32 | US9809582, Example 34 | US...)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354687(US9809582, Example 32 | US9809582, Example 34 | US...)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354687(US9809582, Example 32 | US9809582, Example 34 | US...)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354688(US9809582, Example 33 | US9809582, Example 36 | US...)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354688(US9809582, Example 33 | US9809582, Example 36 | US...)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354659(US9809582, Example 1 | [(1S)-2-(3,5-dichloro-1-oxi...)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354675(US9809582, Example 19)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354659(US9809582, Example 1 | [(1S)-2-(3,5-dichloro-1-oxi...)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354660(US9809582, Example 2)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354660(US9809582, Example 2)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354661(US9809582, Example 3)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354661(US9809582, Example 3)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354662(US9809582, Example 4)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354663(US9809582, Example 5)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354664(US9809582, Example 7)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354667(US9809582, Example 10)
Affinity DataIC50: 5.5nMAssay Description:Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354667(US9809582, Example 10)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354668(US9809582, Example 11)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354675(US9809582, Example 19)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354669(US9809582, Example 12)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM354674(US9809582, Example 18 | Single diastereoisomers of...)
Affinity DataIC50: 5.5nMAssay Description:PDE4B2 activity is detected using the LANCE Ultra cAMP homogeneous time resolved fluorescence resonance energy transfer (TR-FRET) assay from Perkin E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 68 total ) | Next | Last >>
Jump to: